Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205

This study is being done to test a new injection called MWX205 in people with high cholesterol or fat levels in the blood (dyslipidemia). Researchers will check if a single dose of MWX205 is safe and how the body reacts to it. They will also measure how quickly the drug enters the bloodstream and how long it stays in the body, and compare it with a placebo (inactive treatment). The study will help decide the right dose and understand how this medicine could be used in future treatments. The main questions this study aims to answer are: 1. Is MWX205 safe after a single dose? 2. How does the body process MWX205? 3. Does MWX205 show any effect on the body related to cholesterol levels?

NCT Number	NCT07634510
Lead Sponsor	Shanghai Minwei Biotechnology Co., Ltd
Conditions	Dyslipidemias
Enrollment	37 participants
Start Date	2026-06-22
Primary Completion	2026-10-26 (estimated)
Study Completion	2027-11-08 (estimated)
Updated on ClinicalTrials.gov	2026-06-10